Biomedicine & Pharmacotherapy 1991-01-01

Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function.

G Mathé

Index: Biomed. Pharmacother. 45(2-3) , 49-54, (1991)

Full Text: HTML

Abstract

Bestatin, the dipeptide N-((2S, 3R)-3-amino-2-hydroxy-4-phenyl butanyl) L-leucine is a leucine aminopeptidase and aminopeptidase-B inhibitor. It exerts a direct stimulating effect on lymphocytes (and monocytes) via its fixation on cell surface leucine-aminopeptidase, and an indirect effect on monocytes (and lymphocytes) via aminopeptidase B inhibition of tuftsin catabolism. Thus it is an immuno-modifier as shown by the Japanese and also our groups: a) immuno-modifier, especially stimulator, in normal young mice; b) immunorestorator and spontaneous tumor preventive agent in aged mice; c) immunorestorator in the elderly and in cancer patients and HIV infected subjects. It stimulates granulocytopoiesis and thrombocytopoiesis in vitro, and can restore them in vivo in myelo-hypoplastic man. The anti-aminopeptidase action of Bestatin also protects enkephalins against their catabolism, which encouraged us, with good preliminary results, to study its analgesic action and search for a preventive effect on "desaddicted" toxicomaniac relapses.


Related Compounds

Related Articles:

Nerve growth factor-induced synapse-like structures in contralateral sensory ganglia contribute to chronic mirror-image pain.

2015-11-01

[Pain 156 , 2295-309, (2015)]

Chemical genetics reveals a complex functional ground state of neural stem cells.

2007-05-01

[Nat. Chem. Biol. 3(5) , 268-273, (2007)]

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.

2009-10-01

[Nat. Chem. Biol. 5 , 765-71, (2009)]

Involvement of a P2X7 Receptor in the Acrosome Reaction Induced by ATP in Rat Spermatozoa.

2015-12-01

[J. Cell Physiol. 230 , 3068-75, (2015)]

ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface.

2015-02-01

[Cytokine 71(2) , 238-45, (2015)]

More Articles...